Prospeo
Hero Section BackgroundHero Section Background
StemImmune

StemImmune Revenue

Biotechnology ResearchFlag of USSan Diego, California, United States1-10 Employees

$

StemImmune revenue & valuation

Annual revenue$85,555
Revenue per employee$86,000
Estimated valuation?$273,776
Total fundingNo funding

Key Contact at StemImmune

Flag of US

Aladar A. Szalay

Chief Executive Officer, Founder & Chairman

Company overview

Headquarters3655 Nobel Drive #490, San Diego, CA 92122, US
Phone number+13038930552
Website
NAICS541714
Keywords
Stem Cells, Immuno-Oncology, Cancer Therapy, Immunotherapy For Cancer
Founded2014
Employees1-10
Socials

About StemImmune

StemImmune's mission is to revolutionize cancer treatment. Our proprietary immunotherapy platform and delivery methodology leverages autologous (patient’s own) adult stem cells armed with potent, anti-cancer payloads to deliver a powerful attack on cancer.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

StemImmune has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

StemImmune has never raised funding before.

Frequently asked questions

StemImmune is located in San Diego, California, US.
You can reach StemImmune at +13038930552.
StemImmune generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.
StemImmune has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
StemImmune was founded in 2014, making it 12 years old. The company has established itself as a significant player in its industry over this time.
StemImmune has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles